Macrogenics reported $222.18M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US USD 22.19B 1.88B
AstraZeneca AZN:LN USD 22.59B 2.37B
Biogen BIIB:US USD 9.79B 25.4M
Daiichi Sankyo 4568:JP JPY 1.44T 19.68B
Genmab GEN:DC DKK 28.38B 362M
Geron GERN:US USD 180.25M 41.82M
Gilead Sciences GILD:US USD 15.23B 1.67B
Immunogen IMGN:US USD 304.12M 26.3M
Karyopharm Therapeutics KPTI:US USD 356.48M 133.8M
Macrogenics MGNX:US USD 222.18M 74.37M
Mirati Therapeutics MRTX:US USD 1.11B 116.82M
Puma Biotechnology PBYI:US USD 134.28M 11.93M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 33.82B 3.5B
Seattle Genetics SGEN:US USD 2.8B 42.91M
Xencor XNCR:US USD 675.34M 7.34M